Table 1. Clinical and molecular characteristics of patients.
| Disease | n° of pts | % of JAK2 mut pts | % of CALR mut pts |
|---|---|---|---|
| PV | 25 | 28 | 8 |
| ET | 38 | 13 | 40 |
| PMF | 12 | 17 | 25 |
| Controls | 7 | 0 | 0 |
PV: polycythemia vera; ET: essential thrombocythemia; PMF: primary myelofibrosis
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.